Literature DB >> 18037081

Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study.

Henrik Toft Sørensen1, Erzsebet Horvath-Puho, Lars Pedersen, John A Baron, Paolo Prandoni.   

Abstract

BACKGROUND: In some studies, venous thromboembolism has been associated with atherosclerosis and with the risk of arterial cardiovascular events such as myocardial infarction and stroke. Other studies, however, do not show this association. To help clarify these discrepant findings, we aimed to investigate the risk of arterial cardiovascular events in patients who were diagnosed with venous thromboembolism.
METHODS: We undertook a 20-year population-based cohort study using data from nationwide Danish medical databases. After excluding those with known cardiovascular disease, we assessed the risk of myocardial infarction and stroke in 25,199 patients with deep venous thrombosis, 16,925 patients with pulmonary embolism, and 163,566 population controls.
FINDINGS: For patients with deep venous thrombosis, the relative risks varied from 1.60 for myocardial infarction (95% CI 1.35-1.91) to 2.19 (1.85-2.60) for stroke in the first year after the thrombotic event. For patients with pulmonary embolism, the relative risks in that year were 2.60 (2.14-3.14) for myocardial infarction and 2.93 (2.34-3.66) for stroke. The relative risks were also raised, though less markedly, during the subsequent 20 years of follow-up, with 20-40% increases in risk for arterial cardiovascular events. Relative risks were similar for those with provoked and unprovoked deep venous thrombosis and pulmonary embolism.
INTERPRETATION: Patients with venous thromboembolism have a substantially increased long-term risk of subsequent arterial cardiovascular events.

Entities:  

Mesh:

Year:  2007        PMID: 18037081     DOI: 10.1016/S0140-6736(07)61745-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  82 in total

Review 1.  Acute pulmonary embolism. Part 1: epidemiology and diagnosis.

Authors:  Renée A Douma; Pieter W Kamphuisen; Harry R Büller
Journal:  Nat Rev Cardiol       Date:  2010-07-20       Impact factor: 32.419

2.  Patient-reported health preferences of anticoagulant-related outcomes.

Authors:  Ye Wang; Feng Xie; Ming Chai Kong; Lai Heng Lee; Heng Joo Ng; Yu Ko
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

3.  Long-term health outcomes in patients with Prader-Willi Syndrome: a nationwide cohort study in Denmark.

Authors:  E Hedgeman; S P Ulrichsen; S Carter; N C Kreher; K P Malobisky; M M Braun; J Fryzek; M S Olsen
Journal:  Int J Obes (Lond)       Date:  2017-06-21       Impact factor: 5.095

4.  Risk Factors for Venous Thromboembolism in Chronic Obstructive Pulmonary Disease.

Authors:  Victor Kim; Nishant Goel; Jinal Gangar; Huaqing Zhao; David E Ciccolella; Edwin K Silverman; James D Crapo; Gerard J Criner
Journal:  Chronic Obstr Pulm Dis       Date:  2014

5.  Can venous thromboembolism navigate the prevention of cardiovascular complications?

Authors:  Alena Shantsila; Gregory Y H Lip
Journal:  Ann Transl Med       Date:  2015-06

6.  Sauna bathing reduces the risk of venous thromboembolism: a prospective cohort study.

Authors:  Setor K Kunutsor; Timo H Mäkikallio; Hassan Khan; Tanjaniina Laukkanen; Jussi Kauhanen; Jari A Laukkanen
Journal:  Eur J Epidemiol       Date:  2019-08-01       Impact factor: 8.082

7.  Hematocrit and risk of venous thromboembolism in a general population. The Tromso study.

Authors:  Sigrid K Braekkan; Ellisiv B Mathiesen; Inger Njølstad; Tom Wilsgaard; John-Bjarne Hansen
Journal:  Haematologica       Date:  2009-10-14       Impact factor: 9.941

Review 8.  The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease.

Authors:  Mingming Ning; Eng H Lo; Pei-Chen Ning; Su-Yu Xu; David McMullin; Zareh Demirjian; Ignacio Inglessis; G William Dec; Igor Palacios; Ferdinando S Buonanno
Journal:  Pharmacol Ther       Date:  2013-03-23       Impact factor: 12.310

Review 9.  Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?

Authors:  A Maraveyas; M Johnson
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

10.  Venous and arterial thrombosis: Two aspects of the same disease?

Authors:  Paolo Prandoni
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.